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Secondary bacterial infection is a common sequela
to viral infection and is associated with increased
lethality and morbidity. However, the underlying
mechanisms remain poorly understood. We show
that the TLR3/MDA5 agonist poly I:C or viral infection
dramatically augments signaling via the NLRs Nod1
and Nod2 and enhances the production of proinflam-
matory cytokines. Enhanced Nod1 and Nod2 sig-
naling by poly I:C required the TLR3/MDA5 adaptors
TRIF and IPS-1 and was mediated by type I IFNs.
Mechanistically, poly I:C or IFN-b induced the
expression of Nod1, Nod2, and the Nod-signaling
adaptor Rip2. Systemic administration of poly I:C or
IFN-b or infection with murine norovirus-1 promoted
inflammation and lethality in mice superinfected
with E. coli, which was independent of bacterial
burden but attenuated in the absence of Nod1/Nod2
or Rip2. Thus, crosstalk between type I IFNs and
Nod1/Nod2signalingpromotesbacterial recognition,
but inducesharmful effects in the virally infectedhost.
INTRODUCTION
Bacterial superinfection in the context of ongoing viral infection is
a relatively common event that can be associated with increased
morbidity and mortality. For instance, influenza viral infection
increases the susceptibility to several respiratory bacterial path-
ogens (Beadling and Slifka, 2004; Brundage, 2006). Similarly,
varicella has been reported to predispose human to severe
streptococcal and staphylococcal infection (Barnes et al.,
1996; Zerr et al., 1999). Consistent with the human studies, infec-
tion of mice with multiple viruses increases the sensitivity and496 Cell Host & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inlethality to bacterial products, including lipopolysaccharide
(LPS) (Doughty et al., 2001; Feje´r et al., 2005; Nansen and
Randrup Thomsen, 2001). The mechanism whereby viral infec-
tions enhance and aggravate bacterial superinfection is poorly
understood, but it is likely to involve multiple factors, including
local destruction of antibacterial barriers at epithelial surfaces,
suppression of antibacterial immunity, induction of apoptosis
in immune cells, and sensitization to LPS (Doughty et al., 2001;
Feje´r et al., 2005; Herold et al., 2008; Jamieson et al., 2010;
Nansen and Randrup Thomsen, 2001; Navarini et al., 2006).
Detection of viruses and bacteria by host cells is mediated by
the recognition of conserved and unique microbial structures by
pattern-recognition molecules, such as the Toll-like receptors
(TLRs), nucleotide-binding oligomerization domain (NOD)-like
receptors (NLRs), and RIG-like helicases (Akira et al., 2006; Kan-
neganti et al., 2007). TLRs mediate bacterial recognition of
several molecules, including LPS and microbial nucleic acids,
at the cell surface or by endosomes (Akira et al., 2006). In
contrast, NLRs and RIG-like helicases induce innate immune
responses through cytosolic sensing of bacterial and viral
components (Kanneganti et al., 2007; Ting and Davis, 2005).
Two NLR family members, Nod1 and Nod2, are activated by
molecules produced during the synthesis and/or degradation
of bacterial peptidoglycan (PGN) (Chamaillard et al., 2003; Girar-
din et al., 2003a, 2003b; Inohara et al., 2003). Nod1 activation is
triggered by g-D-glutamyl-meso-diaminopimelic acid (meso-
DAP), which is unique to PGN structures from all Gram-negative
bacteria and certain Gram-positive bacteria, whereas Nod2 is
activated by muramyl dipeptide (MDP), a PGN motif present in
all Gram-negative and -positive bacteria (Chamaillard et al.,
2003; Girardin et al., 2003a, 2003b; Inohara et al., 2003). Once
activated, Nod1 and Nod2 induce transcription of immune
response genes through the NF-kB transcription factor and the
mitogen-activated protein kinase (MAPK) signaling pathways
(Chamaillard et al., 2003; Girardin et al., 2003a, 2003b; Inohara
et al., 2003; Kobayashi et al., 2005). In contrast, the RIG-like heli-
cases RIG-I and melanoma differentiation-associated gene 5c.
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Crosstalk between Nod1/Nod2 and Type I IFNs(MDA5) recognize short double-stranded (ds) RNAs with a 50
triphosphate end and long dsRNAs such as polyinosinic poly-
cytidylic acid (poly I:C), respectively (Kato et al., 2006; Yoneyama
et al., 2004). Upon activation, RIG-I and MDA-5 induce type I
IFNs via IFN-b promoter stimulator-1 (IPS-1), also known as
MAVS/Cardif/VISA (Kawai et al., 2005). IPS-1 subsequently
activates two IkB kinase (IKK)-related kinases, IKK-i and
TANK-binding kinase 1 (TBK1). These kinases phosphorylate
IFN-regulatory factor (IRF) 3 and IRF7, which initiate the tran-
scription of type I IFNs (Kawai et al., 2005).
The interaction betweenmicroorganisms and host cells during
microbial infection triggers immune responses that include the
production of proinflammatory molecules. Although proinflam-
matory cytokines are critical for bacterial killing and activation
of adaptive immunity, excessive amounts of certain cytokines
such as TNF-a produced in response to infection are harmful
to the host and can lead to septic shock and multiorgan failure
(Cook et al., 2004; Danner et al., 1991). During infection with
viruses, TLR and RIG-I-like receptor activation induce produc-
tion of type I IFNs, which can potentiate the inflammatory
response to TLR ligands, including LPS (Doughty et al., 2001;
Nansen and Randrup Thomsen, 2001). In addition, viral infection
can augment or repress the immune response to bacteria (Nav-
arini et al., 2006). However, the innate signaling pathways acti-
vated in response to secondary infection with bacteria that
promote lethality in virally infected hosts remain poorly under-
stood. We provide evidence that viral infection enhances the
response to bacteria through Nod1 and Nod2 signaling path-
ways. The enhanced activation of Nod1 and Nod2 induced by
secondary bacterial infection was mediated by type I IFNs and
contributed to TNF-a production and lethality in virally infected
mice.
RESULTS
Poly I:C Augments Nod2 Activation via TRIF- and
IPS-1-Dependent Signaling Pathways in Macrophages
To examine a possible link between viral infection and Nod2
signaling, mouse bone-marrow-derived macrophages (BMDMs)
were prestimulated with poly I:C, a synthetic dsRNA analog that
mimics viral infection, and 24 hr later withMDP, a Nod2microbial
activator. As a control, macrophages were stimulated with LPS
(TLR4 agonist) or N-palmitoyl-S-[2,3-bis(palmitoyloxy)-propyl]-
(R)-cysteinyl-(lysyl)3-lysine (pam3CSK4) (TLR2 agonist) followed
by MDP. Stimulation with MDP induced JNK, ERK, and p38
phosphorylation as well as IkB-a degradation, which was greatly
enhanced in cells pretreated with LPS and poly I:C, but little or
not at all with the TLR2 agonist (Figure 1A). As expected, the
enhancement of Nod2-dependent signaling induced by LPS
was abrogated in Myd88/Ticam1/ macrophages, the two
adaptors that mediate all TLR signaling (Figure 1A). In contrast,
MAPK and NF-kB activation induced by MDP in macrophages
prestimulated with poly I:C was partially reduced in
Myd88/Ticam1/macrophages (Figure 1A). Poly I:C is known
to induce signaling through TLR3-TRIF and MDA5-IPS-1
signaling pathways (Kumar et al., 2008). In line with this,
augmentation of MDP-induced signaling was reduced in Tlr3/
andMavs/macrophages and abrogated in Ticam1/Mavs/
macrophages (Figures 1B–1D). Consistently, TNF-a and IL-6Cell Hsecretion was induced by MDP in macrophages prestimulated
with poly I:C, but not in untreated macrophages, and the secre-
tion of these cytokines was abolished in Ticam1/Mavs/ cells
(Figure 1E). Unlike the response to MDP, production of TNF-a
induced by pam3CSK4 stimulation was unimpaired in Nod2/
or Ticam1/Mavs/ macrophages (Figure S1). These results
indicate that poly I:C enhances Nod2 signaling via TRIF- and
IPS-1, enabling the macrophages to secrete cytokines in
response to MDP.
Enhancement of Nod2 Signaling by Poly I:C
and the Chemotherapeutic Molecule DMXAA
Is Mediated by Type I IFNs
Type I IFNs are induced by poly I:C via TRIF- and IPS-1-depen-
dent signaling (Kumar et al., 2008). To determine whether type I
IFN production is important in augmenting Nod2 activation, WT
and mutant macrophages deficient in the type I IFN receptor
(IFNAR1) were prestimulated with poly I:C and then MDP. We
found that poly I:C-mediated enhancement of JNK, ERK, and
p38 phosphorylation as well as IkB-a degradation in response
to MDP was greatly inhibited in the absence of IFNAR1 (Fig-
ure 2A). Consistently, MDP stimulation induced IL-6 and TNF-a
inmacrophages prestimulatedwith poly I:C or DMXAA, a chemo-
therapeutic drug in clinical trials that activates the IRF-3 and type
I IFNs (Roberts et al., 2007), but not in the absence of prestimu-
lation (Figure 2B). Notably, the production of TNF-a and IL-6
induced by MDP was abrogated in Ifnar1/ or Nod2/ macro-
phages (Figures 2B and 2D). In addition, pretreatment with
DMXAA or IFN-b augmented MAPK and NF-kB activation in
response to MDP, which was abolished in macrophages lacking
IFNAR1 (Figure 2C). In contrast, the production of TNF-a induced
by DMXAA and IFN-b required IFNAR1, but not TRIF/IPS-1 (Fig-
ure S2), which is consistent with the fact that these two mole-
cules act downstream of the TRIF/IPS-1 adaptors to induce
type I IFNs. These results indicate that Nod2 signaling is
enhanced by poly I:C and the chemotherapeutic molecule
DMXAA through the production of type I IFNs.
Type I IFN Signaling Induces Expression of Nod1, Nod2,
and Rip2
RIP2 is the essential adaptor that mediates gene induction in
response to Nod1 and Nod2 agonists (Park et al., 2007). To
assess whether the expression of Rip2 is regulated by type I
IFN production, macrophages were stimulated with poly I:C,
DMXAA, or IFN-b, and the amount of Rip2 in cell extracts was
determined by immunoblotting. All three stimuli enhanced Rip2
production, which was first detected by 3 hr and further
increased by 12–24 hr of stimulation (Figure 3A). Furthermore,
induction of Rip2 in response to poly I:C was abrogated in
Ticam1/Mavs/ or Ifnar1/ macrophages (Figure 3B). In
contrast, enhanced Rip2 production in response to DMXAA
and IFN-b required IFNAR1, but not TRIF/IPS-1 (Figure 3B),
which is consistent the results shown in Figure S2. In addition,
stimulation of macrophages with poly I:C, DMXAA, and IFN-b
induced the expression of Nod1 and Nod2 mRNA (Figure 3C).
The induction of Nod1 and Nod2 by poly I:C, DMXAA, and
IFN-b was impaired in Ifnar1/ macrophages (Figure 3D). In
contrast, enhanced Nod1 and Nod2 expression by DMXAA
and IFN-b was unimpaired in Ticam1/Mavs/ macrophagesost & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inc. 497
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Figure 1. Poly I:C Augments Nod2 Activation via TRIF- and IPS-1-Dependent Signaling Pathways in Macrophages
(A–D) BMDMs from WT and indicated mutant mice were left untreated () or pretreated with LPS (A), pam3CSK4 (A), or poly I:C (A–D) for 24 hr and then
restimulated with MDP. Cell extracts were collected at the indicated times and assessed for MAPK and NF-kB activation using phosphospecific antibodies.
(E) BMDMs from WT and Ticam1/Mavs/ mice were treated with poly I:C or left untreated for 24 hr. The macrophages were then restimulated with MDP.
Cell-free supernatants were analyzed by ELISA for production of IL-6 and TNF-a (***p < 0.001, compared with untreated and poly I:C-treated or WT and mutant
macrophage cultures). N.D. denotes not detected. Results are representative of two or three independent experiments. Data are expressed as mean ± SD.
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Crosstalk between Nod1/Nod2 and Type I IFNs(Figure 3D), in line with the Rip2 results shown in Figure 3B.
These results indicate that Type I IFNs induce expression of
Nod1 and Nod2 as well as Rip2, the mediator of Nod1 and
Nod2 signaling.
Viral Infection Augments Nod1 and Nod2 Signaling
We next determined whether infection of macrophages with
viruses augments Nod2 signaling. Macrophages were infected
with murine norovirus-1 (MNV-1) or vesicular stomatitis virus
(VSV) for 24 hr and then stimulated with MDP. Viral infection
enhanced JNK, ERK, and p38 phosphorylation in response to
MDP when compared to that observed in uninfected cells
(Figures 4A and 4B). Consistently, MDP induced IL-6 and
TNF-a production in macrophages previously infected with
MNV-1 or VSV, but not in uninfected cells (Figures 4C and 4D).
In addition, infection with MNV-1 or stimulation with poly I:C,
DMXAA, or IFN-b augmented MAPK and NF-kB activation
induced by KF1B, a synthetic molecule containing the iE-DAP
dipeptide that activates Nod1 (Figures 4E and 4F). Consistent498 Cell Host & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inwith Figure 3C, infection of macrophages with MNV-1 induced
the expression of Nod1 and Nod2 (Figure 4G). To determine
whether viral infection affects Nod2 signaling in macrophages
in vivo,micewere injected i.p.with thioglycollate, and 3days later
the mice were infected i.p. with MNV-1 or PBS as a control, and
peritoneal macrophages were purified for analysis ex vivo 24 hr
later. Exposure of macrophages to MNV-1 in vivo enhanced the
activation of JNK, ERK, p38, and IkB-a degradation in response
to MDP when compared to macrophages derived from unin-
fected mice (Figure 4H). Collectively, these results indicate
that viral infection enhances Nod1 and Nod2 signaling in
macrophages.
Nod1 and Nod2 Contribute to Bacteria-Induced
TNF-a Production and NF-kB Activation in Macrophages
Infected with MNV-1
We next determined the role of Nod1 and Nod2 in mediating the
inflammatory response induced by Gram-negative bacteria in
macrophages treated with poly I:C or infected with MNV-1.c.
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Figure 2. Enhancement of Nod2 Signaling by Poly I:C and the Chemotherapeutic Molecule DMXAA Is Mediated via Type I IFNs
(A) BMDMs from WT and Ifnar1/ mice were left untreated (control) or pretreated with poly I:C (A) for 24 hr and then restimulated with MDP. Cell extracts were
collected at the indicated times and assessed for MAPK and NF-kB activation using phosphospecific antibodies.
(B) BMDMs fromWTor Ifnar1/micewere treatedwith poly I:C or DMXAA or left untreated for 24 hr and then restimulated withMDP. Cell-free supernatants were
analyzed for production of IL-6 and TNF-a (***p < 0.001, compared with WT and mutant macrophage cultures). N.D. denotes not detected. Results are repre-
sentative of three independent experiments. Data are expressed as mean ± SD.
(C) BMDMs from WT and Ifnar1/ mice were left untreated (control) or pretreated with DMXAA or IFN-b for 24 hr and then restimulated with MDP. Cell extracts
were collected at the indicated times and assessed for MAPK and NF-kB activation using phosphospecific antibodies.
(D) BMDMs fromWT orNod2/micewere treatedwith poly I:C or DMXAA or left untreated for 24 hr and then restimulated withMDP. Cell-free supernatants were
analyzed for production of IL-6 and TNF-a (***p < 0.001, compared with WT and mutant macrophage cultures). N.D. denotes not detected. Results are repre-
sentative of three independent experiments. Data are expressed as mean ± SD.
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Crosstalk between Nod1/Nod2 and Type I IFNsProduction of TNF-a and IL-6 in response to E. coli or
P. aeruginosa was independent of Nod1 and Nod2 in unstimu-
lated macrophages (Figures 5A, 5B, and S3). Notably, pretreat-
ment with poly I:C or infection with MNV-1 augmented the
production of TNF-a and IL-6 induced by infection with E. coli
or P. aeruginosa (Figures 5A, 5B, and S3). Importantly, the
enhancement of TNF-a and IL-6 was significantly attenuated in
Nod1/Nod2/ macrophages (Figures 5A, 5B, and S3) and
Ripk2/ macrophages (Figure 5C). In agreement with these
results, IkB-a phosphorylation and degradation induced by
infection with E. coli was comparable in untreated macrophages
from WT and Nod1/Nod2/ mice (Figure 5D), but reduced in
Nod1/Nod2/ macrophages when the cells were previously
treated with poly I:C or infected with MNV-1 (Figure 5D). In addi-
tion, JNK and ERK phosphorylation was diminished in
Nod1/Nod2/ macrophages treated with poly I:C or infected
with MNV-1 when compared to WT cells (Figure 5D). These
results indicate that Nod1 and Nod2 contribute to bacteria-
induced TNF-a production and NF-kB activation in macro-
phages infected with MNV-1 followed by Gram-negative
bacteria infection.
Nod1 and Nod2 Signaling Potentiate TNF-a Production
and Lethality Induced by Secondary Bacterial Infection
in Mice Treated with Poly I:C or Infected with MNV-1
We next examined the role of Nod1 and Nod2 in regulating the
susceptibility of virus-infected mice to bacteria. To test this, we
first treated groups of WT and Nod1/Nod2/ mice with PBS
or poly I:C i.p. for 24 hr, then infected the mice with E. coli andCell Hmonitored mouse survival. We found that a dose of 3 3 108 cfu
ofE. coli induced lethality in 100%of themice previously injected
i.p. with poly I:C (Figure S4A). Using this dose of E. coli, all WT
and mutant mice that were treated with PBS survived the infec-
tion (Figure 6A). In contrast, 100% of the WT mice treated with
poly I:C succumbed to E. coli infection, whereas 30% of the
Nod1/Nod2/ mice survived (Figure 6A). The increased
mortality induced by poly I:C administration was associated
with increased amounts of TNF-a in the serum of WT and
Nod1/Nod2/ mice (Figure 6B). Importantly, there was
reduced production of TNF-a in Nod1/Nod2/ mice
compared to WT mice in animals treated with poly I:C and
infected with E. coli (Figure 6B). We also found that intraperito-
neal administration of poly I:C promoted lethality in mice infected
intranasally (i.n.) with P. aeruginosa (Figures 6C and S4B). As it
was found in the E. colimodel, lethality was significantly attenu-
ated in Nod1/Nod2/ mice, which correlated with reduced
TNF-a production in the lung (Figure 6D).
To test more directly the role of Nod1 and Nod2 signaling in
the context of viral infection, WT, Nod1/Nod2/, or Ripk2/
mice were infected with MNV-1 orally, the normal route of
infection, and then challenged with E. coli. All mock-infected
mice, regardless of genotype, survived the infection with
E. coli (Figure 6E). Consistent with the results observed with
poly I:C, 30% of the Nod1/Nod2/ or Ripk2/ mice in-
fected with MNV-1 survived, whereas 100% of the WT mice
succumbed after infection with E. coli (Figure 6E). Similar
results were obtained when the mice were infected with
MNV-1 via the i.p. route (Figures S4C and S4D). The increasedost & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inc. 499
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(A) BMDMs from WT mice were treated with poly I:C, DMXAA, or IFN-b for the indicated times, and cell extracts were assessed for Rip2 and a-tubulin levels
by immunoblotting.
(B) BMDMs fromWT, Ticam1/Mavs/, and Ifnar1/mice were treated with poly I:C, DMXAA, or IFN-b for 24 hr, and cell extracts were assessed for Rip2 and
a-tubulin levels by immunoblotting.
(C) BMDMs from WT mice were treated with poly I:C, DMXAA, or IFN-b for the indicated times, and total RNA was isolated to analyze for Nod1 and Nod2
expression. Gene expression was normalized to that of b-actin.
(D) BMDMs from WT, Ticam1/Mavs/, and Ifnar1/ mice were treated with poly I:C, DMXAA, or IFN-b for 8 hr, and total RNA was isolated to analyze
expression of Nod1 and Nod2. *p < 0.05, ***p < 0.001, comparison between untreated and treated macrophage cultures. Results are representative of two or
three independent experiments. Data are expressed as mean ± SD.
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Crosstalk between Nod1/Nod2 and Type I IFNssurvival of Nod1/Nod2/ was not explained by altered
IFN-b production, because infection of dendritic cells derived
from the bone marrow of WT, Nod1/, Nod2/, or
Nod1/Nod2/ mice with MNV-1 induced comparable
amounts of IFN-b (Figure S4E). Furthermore, oral infection of
WT, Nod1/, Nod2/, or Nod1/Nod2/ mice with MNV-1
induced comparable levels of IFN-b in the serum (Figure S4F).
Thus, Nod1 and Nod2 did not regulate the production of
IFN-b in response to MNV-1 infection. The effect on lethality
induced by secondary infection with E. coli in WT and
Nod1/Nod2/ mice was not correlated with different bacte-
rial loads in lung, blood (Figures 6F and 6G), or spleen (Fig-
ure S4G). As it was observed after poly I:C administration,
infection with MNV-1 augmented the production of TNF-a in500 Cell Host & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inthe serum, which was associated with increased lethality in
E. coli-infected mice (Figure 6H). Furthermore, increased sur-
vival of Nod1/Nod2/ or Ripk2/ mice was correlated
with reduced amounts of TNF-a in the serum of mutant animals
when compared to WT mice (Figure 6H), but not with IL-6
production (Figure S4H). To determine whether TNF-a plays
a role in the increased lethality of WT mice, we injected the
mice with a blocking anti-TNF-a or control antibody. Adminis-
tration of the anti-TNF-a antibody significantly delayed the
death of the mice induced by infection with MNV-1 and
E. coli when compared to mice treated with control antibody
(Figure 6I). Thus, infection with MNV-1 increases lethality
induced by secondary infection with E. coli, and this is medi-
ated, in part, by TNF-a production.c.
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Figure 4. Viral Infection Augments Nod1 and Nod2 Signaling
(A and B) BMDMs from WT mice were mock infected () or infected with MNV-1 at moi of 0.1 and 0.3 (A) or VSV at moi of 0.002 and 0.01 (B) for 24 hr and then
restimulated with MDP. Cell extracts were collected at the indicated times and assessed for MAPK and NF-kB activation using phosphospecific antibodies.
(CandD)BMDMsfromWTmiceweremock infected () or infectedwithMNV-1atmoiof 0.3orVSVatmoiof 0.01 for 24hr. Themacrophageswere then restimulated
with MDP. Cell-free supernatants were analyzed for IL-6 (C) and TNF-a (D) production (***p < 0.001, compared with mock-infected and infected cultures).
(E and F) BMDMs fromWTmice were left untreated () or treatedwith poly I:C, DMXAA, or IFN-b (E) or infected withMNV-1 (F) for 24 hr and then restimulated with
the Nod1 ligand KF1B. Cell extracts were collected at the indicated times and assessed for MAPK and NF-kB activation using phosphospecific antibodies.
(G) BMDMs from WT mice were infected with MNV-1 for the indicated times, and total RNA was isolated to analyze for the expression of Nod1 and Nod2.
(H) WT mice were injected i.p. with thioglycollate for 3 days and then treated with PBS () or infected with MNV-1 (1 3 106 pfu/mouse) i.p. Elicited peritoneal
macrophages were isolated 24 hr after MNV-1 infection and stimulated with MDP ex vivo. Cell extracts were collected at the indicated time and assessed for
MAPK and NF-kB activation using phosphospecific antibodies. Data are expressed as mean ± SD. Results are representative of three independent experiments.
Cell Host & Microbe
Crosstalk between Nod1/Nod2 and Type I IFNsIFN-b Enhances MDP-Induced Cytokine Production
In Vivo and Promotes Bacteria-Induced Lethality
via Nod1 and Nod2
Wenext assessedwhether administration of IFN-bwas sufficient
to enhance Nod2 signaling in vivo. To determine this, WT mice
were given murine PEGylated IFN-b or PBS i.p., and 18 hr later
the mice were stimulated with MDP, the Nod2 agonist. Adminis-
tration of IFN-b enhanced the serum levels of IL-6 and CCL2, two
molecules that are induced byMDP stimulation in vivo (Kim et al.,
2008; Magalhaes et al., 2008), in WT but not in Nod2/ mice
(Figure 7A). Furthermore, serum TNF-a production in response
to E. coli infection was enhanced by pretreatment with unmodi-
fied or PEGylated murine IFN-b (Figure 7B). To determine
whether administration of IFN-b promotes mouse lethality, WT
and Nod1/Nod2/ mice were given PEGylated IFN-b or
PBS i.p., and 18 hr later the mice were infected with E. coli andCell Hmonitored for survival. We found that 30% of the WT mice suc-
cumbed to bacterial infection when the mice were given IFN-b,
whereas no lethality was observed in PBS-treated mice or IFN-
b-treated Nod1/Nod2/ animals (Figure 7C). The increased
mortality induced by IFN-b administration was associated with
increased amounts of TNF-a in the serumofWTmice (Figure 7D).
These results indicate that IFN-b is sufficient to enhance Nod2
signaling and to promote bacteria-induced lethality in vivo.
Furthermore, IFN-b-induced lethality in mice infected with
E. coli required Nod1 and Nod2.
DISCUSSION
Viral infections are potent stimuli for type I IFN production, which
is induced via the recognition of viral RNA by TLR3, TLR7, and
RIG-I helicases (Takeuchi and Akira, 2010). Our results indicateost & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inc. 501
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Figure 5. Nod1 and Nod2 Contribute to Bacteria-Induced TNF-a Production and NF-kB Activation in Macrophages Infected with MNV-1
(A and B) BMDMs fromWT andNod1/Nod2/micewere left untreated, treated with poly I:C, or infected withMNV-1 for 24 hr and then infected with live E. coli
(A) or P. aeruginosa (B) at a bacteria/macrophage ratio (B/M) of 1, 5, and 10. Cell-free supernatants were analyzed for production of TNF-a (*p < 0.05, **p < 0.01,
***p < 0.001, compared with WT and mutant macrophages cultures).
(C) BMDMs from WT and Ripk2/ mice were left untreated, treated with poly I:C, or infected with MNV-1 for 24 hr and then infected with live E. coli or
P. aeruginosa at a bacterial/macrophage ratio (B/M) of 1. Cell free supernatants were analyzed for production of TNF-a (*p < 0.05, **p < 0.01, compared with WT
and mutant macrophage cultures).
(D) BMDMs fromWT andNod1/Nod2/mice were left untreated or treatedwith poly I:C or infectedwithMNV-1 for 24 hr and then infectedwith E. coli at bacteria/
macrophage ratio of 10 for the indicated times. Cell extracts were assessed for MAPK, NF-kB activation, and a-tubulin levels by immunoblotting. Data are
expressed as mean ± SD. Results are representative of three independent experiments.
Cell Host & Microbe
Crosstalk between Nod1/Nod2 and Type I IFNsthat type I IFNs elicited by enteric or systemic infection with the
MNV-1 virus augment the response to Nod1/Nod2 stimulation,
and these coordinated signaling events contribute to lethality
associated with secondary E. coli infection. The protection
afforded by deficiency in Nod1/Nod2 or Rip2 against E. coli
infection in mice treated with poly I:C or IFN-b or infected with
MNV-1 correlated with reduced TNF-a levels. However, the
inhibition of mouse lethality induced by TNF-a blockade was
partial, indicating that other proinflammatory mediators induced
by enhanced Nod1/Nod2 signaling are also critical for lethality.
The latter results are consistent with observations indicating
that various molecules produced during bacterial sepsis,
including TNF-a, IL-1b, IFN-g, and MIF, contribute to lethality
(Bernhagen et al., 1993; Beutler et al., 1985; Car et al., 1994; Fan-
tuzzi et al., 1996). The role of proinflammatory molecules such as502 Cell Host & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier InTNF-a in bacterial infection is complex in that they contribute to
host defense, but also promote organ damage and lethality,
particularly in the presence of high numbers of bacteria (Beutler
et al., 1985). Thus, these studies suggest that overstimulation of
Nod1/Nod2 by E. coli promotes the overproduction of harmful
proinflammatory molecules such as TNF-a that mediate lethality
in virally infected mice.
Several lines of evidence support our conclusions that viral
infection promoted by type I IFNs increases innate recognition
of bacteria and lethality. First, enhancement of MDP-induced
NF-kB and MAPK activation by poly I:C were abolished in
macrophages deficient in IFNAR1 or innate immune receptors
that are required for IFN-a/b production. Second, stimulation
with IFN-b or DMXAA, a synthetic molecule that activates IRF3,
was sufficient to enhance Nod1 and Nod2 signaling in vitroc.
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Figure 6. Murine Norovirus Infection Promotes Bacteria-Induced TNF-a Production and Lethality in Mice via Nod1 and Nod2
(A and B)WT andNod1/Nod2/mice were injected i.p. with PBS (n = 5) or poly I:C (200 mg/mouse, n = 10) and then infected with E. coli 33 108 cfu /mouse i.p.
24 hr after poly I:C administration. Lethality wasmonitored for 5 days after infection (A). At 3 hr postinfection, the levels of TNF-a in serumwere assessed by ELISA
(n = 5 or 10) (B).
(C and D) WT and Nod1/Nod2/ mice were injected with PBS or poly I:C (200 mg/mouse) i.p. and then infected with P. aeruginosa 2.5 3 107 cfu /mouse i.n.
24 hr after poly I:C administration. Lethality was monitored for 5 days after infection (n = 10–11) (C). At 3 hr postinfection, the level of TNF-a in lung homogenates
was assessed by ELISA (n = 6) (D).
(E–I) WT, Nod1/Nod2/, and Ripk2/mice were mock infected or infected orally with MNV-1 (13 107 pfu/mouse) and then infected with E. coli 33 108 cfu/
mouse i.p. 24 hr after the MNV-1 infection. Lethality was monitored for 5 days after E. coli infection (n = 9–10) (E). Bacterial loads in lung (F) and blood (G) samples
were determined at 8 hr postinfection by plating (n = 7–8). The short black horizontal lines show the mean values for the groups. Each symbol represents one
animal. N.S. denotes not significant. At 3 hr postinfection, serum TNF-a levels were assessed by ELISA (n = 9–10). N.S. denotes not significant (H). One hour
before E. coli infection, WTmice were injected i.p. with control rat IgG or anti-TNF-a rat IgG, and lethality was monitored for 5 days after infection (n = 10) (I). Data
are expressed as mean ± SD. Results are representative of two or three independent experiments.
Cell Host & Microbe
Crosstalk between Nod1/Nod2 and Type I IFNsand in vivo. Third, type I IFNs induced the expression of Nod1,
Nod2, and Rip2, the essential kinase that is required for Nod1
and Nod2 signaling. Fourth, Nod1/Nod2/ mice infected
with MNV-1 virus or stimulated with poly I:C were partially pro-
tected from E. coli infection. Although Nod1/Nod2/mice in-
fected with MNV-1 exhibited reduced susceptibility to E. coli
infection, the mutant mice were more susceptible than animals
that were not stimulated with poly I:C or infected with the virus.
Furthermore, the enhancement of TNF-a production by poly
I:C or MNV-1 in macrophages infected with Gram-negative
bacteria was reduced, but not abolished, in Nod1/Nod2/
macrophages. Thus, Nod1 andNod2 contribute to the inflamma-
tory response and lethality induced by bacteria in virally infectedCell Hmice, but additional host factors are involved. Possible candi-
dates for the latter are TLRs, given that type I IFNs enhance
the sensitivity to LPS and susceptibility to LPS-inducedmortality
in mice (Doughty et al., 2001; Nansen and Randrup Thomsen,
2001). Thus, the production of IFN-a/b not only is critical for
the control of viral replication, but also potentiates TLR and
Nod1/Nod2 signaling pathways, which are involved in the recog-
nition of bacteria and mediate the production of harmful cyto-
kines that mediate lethality. Unlike the effect of poly I:C or
MNV-1 infection, we only observed 30% lethality induced by
bacterial infection in mice pretreated with IFN-b. One possibility
is that sustained production of high levels of IFN-b is needed for
100% lethality, and administration of exogenous IFN-b could notost & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Inc. 503
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Figure 7. IFN-b Enhances MDP-Induced Cytokine Production In Vivo and Promotes Bacteria-Induced Lethality via Nod1 and Nod2
(A) WT (n = 7) and Nod2/ (n = 6) mice were injected with PBS or PEGylated murine IFN-b (5 3 103 U/mouse) i.p. and 18 hr later injected with MDP
(300 mg/mouse). Three hours later, the levels of IL-6 and CCL2 in serum were assessed by ELISA.
(B) WT mice (n = 5/group) were injected with PBS or PEGylated murine IFN-b (53 103 U/mouse) i.p. or with unmodified murine IFN-b (2.53 104 U/mouse, twice,
separated by 3 hr) subcutaneously (s.c.) and 18 hr later infectedwith 33 108 cfu of E. coli/mouse. Three hours postinjectionwith E. coli, the level of TNF-a in serum
was assessed by ELISA.
(C) WT and Nod1/Nod2/mice were injected with PBS (n = 15) or PEGylated murine IFN-b (53 103 U/mouse, n = 15) i.p. and 18 hr later infected with 33 108
cfu of E. coli/mouse i.p. Mouse survival was monitored for 5 days after infection.
(D) Three hours postinfection, the level of TNF-a in serum was assessed by ELISA (n = 9 or 10).
Cell Host & Microbe
Crosstalk between Nod1/Nod2 and Type I IFNsfully mimic endogenous production of IFN-b induced by poly I:C
or MNV-1 infection. An alternative, nonexcluding possibility is
that IFN-b is sufficient to promote lethality, but the partial effect
reflects the additional contribution of signaling pathway(s) such
as NF-kB that are induced by poly I:C or MNV-1 infection.
The biological reason for coupling type I IFNs induced during
viral infection to bacterial recognition is unclear. One possibility
is that it serves to boost the immune response of the virally in-
fected host to bacterial infection, and this may be helpful when
the host is superinfectedwith bacterial pathogens. The enhance-
ment of Nod1 and Nod2 signaling by type I IFNs is associated
with increased NF-kB and MAPK activation, and thus it is ex-
pected to increase the immune response to bacteria and
production of antibacterial molecules. Consistent with this, we
found enhanced production of TNF-a in macrophages and
mice pretreated with poly I:C or infected with MNV-1 in response
to bacteria, which was attenuated in the absence of Nod1/Nod2
or Rip2. However, type I IFN-mediated enhancement of Nod1/
Nod2 signaling is also expected to augment the potentially harm-
ful effect mediated by TNF-a and other proinflammatory mole-
cules in the setting of systemic bacterial infection. The latter
may be particularly relevant in the context of viruses that induce504 Cell Host & Microbe 9, 496–507, June 16, 2011 ª2011 Elsevier Insystemic production of type IFNs and superinfection with high
number of bacteria that induces high levels of TNF-a and
other harmful proinflammatory cytokines. Another nonexcluding
possibility is that the coupling of IFN-a/b production and innate
signaling pathways involved in bacterial recognition primarily
serves to enhance the immune response to viruses, but not to
bacteria, since Nod2 have been also implicated in viral recogni-
tion (Sabbah et al., 2009). However, we found that Nod1 and
Nod2 are not required for IFN-b production in response to
MNV-1 infection in vivo. Another possibility is that the crosstalk
between type I IFN and Nod1/Nod2 signaling is more relevant
to bacterial infection or interactions between two types of
bacteria. For example, many Gram-negative bacteria induce
type I IFNs via TLR4-TRIF signaling, and this will enhance
Nod1/Nod2 signaling and production of inflammatory molecules
in response to bacteria.
In humans, the outcome of bacterial sepsis correlates with the
magnitude of the inflammatory response (Casey et al., 1993;
Sunde´n-Cullberg et al., 2005). The factors that regulate the
strength of the immune response to bacteria in humans are
poorly understood, but are likely to include genetic variation
and age as well as environmental factors. The current workc.
Cell Host & Microbe
Crosstalk between Nod1/Nod2 and Type I IFNsfocused on MNV-1, a virus that models human infection by nor-
oviruses, which are now recognized as being the most common
cause of epidemics of gastroenteritis and an important cause of
sporadic gastroenteritis in both children and adults (Glass et al.,
2009). Although the production of type I IFNs in response to nor-
ovirus infection in humans has not been studied, high levels of
IFN-a/b are found in individuals with certain viral infections
such as that resulting from adenovirus and rotavirus (Gendrel
et al., 1999). Thus, it is possible that the crosstalk between
type I IFNs and signaling pathways activated in response to
bacterial superinfection may contribute to morbidity and mor-
tality in human populations.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were generated through breeding in our animal facility from
breeders purchased from Jackson Laboratories (Bar Harbor, ME). Nod1/,
Nod2/, Nod1/Nod2/, and Ripk2/ in C57BL/6 background have
been described (Kim et al., 2008). Ifnar1/ mice were obtained from Mariana
Kaplan, the University of Michigan. Myd88/Ticam1/, Tlr3/, Mavs/,
and Ticam1/Mavs/ mice have been described (Kumar et al., 2008). The
animal studies were conducted under approved protocols by the University
of Michigan Committee on Use and Care of Animals.
Reagents and Bacterial Infection
Poly I:C and pam3CSK4 (pam3, Invivogen), synthetic MDP (Bachem), Ultra-
pure LPS from E. coli O55:B5 and DMXAA (Sigma), and mouse IFN-b (PBL
Interferon Source) were used at the indicated concentrations. For in vivo
experiments, unmodified (3.5 3 107 U/ml) and PEGylated murine IFN-b
(1.63 106 U/ml) were provided by Biogen Idec Inc., Cambridge, MA (Pepinsky
et al., 2001). Synthetic Nod1 ligand KF1B (Hasegawa et al., 2007) was a gift of
K. Fukase, Osaka University. E. coli strain K-12 was a gift of M. O’Riordan, the
University of Michigan. Pseudomonas aeruginosa strain PAK was a gift of Ste-
phen Lory, Harvard University. Single colonies were inoculated into Luria-
Bertani (LB) medium and grown overnight at 37C with shaking. On the day
of the infection, a 1/10 dilution of the overnight culture was prepared and al-
lowed to grow at 37C with shaking to A600 = 0.5, which corresponds to 2 3
109 cfu/ml. Bacteria were diluted to the desired concentration and used to
infect macrophages at different bacterial/macrophage ratios. After 60 min of
infection at 37C, the macrophages were washed twice with PBS and IMDM
containing 50 mg/ml of gentamycin, which was added to limit the growth of
extracellular bacteria. The plaque-purified murine norovirus-1 (MNV-1) clone
(GV/MNV1/2002/USA) MNV-1.CW3 (Thackray et al., 2007) was used at
passage 6 for all infections. MNV-1 was passaged on RAW 264.7 cells and
concentrated as described (Chachu et al., 2008; Wobus et al., 2004). Vesicular
stomatitis virus (VSV), strain Orsay (ATCC VR-1421), was propagated in
Chinese hamster ovary (CHO) cells.
Preparation and Stimulation of Murine Macrophages
BMDMs were prepared as described previously (Celada et al., 1984). Briefly,
the femurs and tibias from 6- to 12-week-old mice were dissected, and the
bone marrow was flushed out. Bone marrow cells were cultured with IMDM
media supplemented with 30% L929 supernatant containing macrophage-
stimulating factor, glutamine, sodium pyruvate, 10% heat-inactivated fetal
bovine serum (GIBCO-BRL), and antibiotics for 5 days. Macrophages were
cultured in 48-well plates at a concentration of 2 3 105/well or in 6-well plates
at a concentration of 2 3 106 cells/well. The day after the plating, cells were
treated with poly I:C (100 mg/ml), LPS (100 ng/ml), pam3CSK4 (1 mg/ml),
DMXAA (10 mg/ml), and IFN-b (2 3 102 units/ml) or infected with MNV-1
(moi = 0.1 and 0.3) and VSV (moi = 0.002 and 0.01) for 24 hr and then treated
with MDP (10 mg/ml), KF1B (10 mg/ml), LPS (100 ng/ml), pam3CSK4 (pam3,
1 mg/ml), and poly I:C (100 mg/ml) or infected with E. coli or P. aeruginosa. Peri-
toneal macrophages were elicited by intraperitoneal injection of thioglycollate
for 3 days. Thioglycollate-elicited peritoneal macrophages (PMs) were har-
vested by peritoneal lavage with PBS, and adherent cells were enriched byCell Hplastic adherence for 2 hr. One day before isolating PMs, mice were injected
with PBS () or infected with MNV i.p. PMs were then treated with MDP
(10 mg/ml).
Measurement of Cytokines
Mouse cytokines were measured in culture supernatants using enzyme-linked
immunosorbent assay (ELISA) kits from R&D Systems.
Immunoblotting
Cells were lysed in buffer containing 1% NP-40 supplemented with complete
protease inhibitor cocktail (Roche,Mannheim, Germany) and 2mMdithiothrei-
tol. Lysate proteins were separated by SDS-PAGE and transferred to PVDF
membranes by electroblotting (Bio-Rad). Membranes were immunoblotted
with antibodies for mouse IkB-a, phospho-IkB-a, p38, phospho-p38, phos-
pho-ERK, phospho-JNK (Cell Signaling Technology, Beverly, MA), and Rip2
(Enzo Life Sciences International, Inc., Plymouth Meeting, PA).
cDNA Synthesis and Real-Time RT-PCR
Total RNA was extracted from cultured macrophages after stimulation with
poly I:C (100 mg/ml), DMXAA (10 mg/ml), or IFN-b (23 102 units/ml) or infection
with MNV-1 (moi = 0.1) for the indicated periods, using E.Z.N.A Total RNA Kit I
(OMEGA Bio-Tek, Inc.) according to the manufacturer’s instructions. cDNA
was synthesized using High-Capacity RNA-to-cDNA Kit (Applied Biosystems)
according tomanufacturer’s instructions. Real-time PCRwas performed using
SYBR Green Master Mix (Applied Biosystems) at the University of Michigan
Comprehensive Cancer Center Affymetrix and Microarray Core Facility
(University of Michigan, Ann Arbor). The PCR conditions were as follows: initial
denaturation for 10min at 95C, followed by 40 cycles of 15 s at 95Cand 1min
at 60C. The primers sequence was: Nod1 forward, GCCGAAGATGCAGA
GATTGT; Nod1 reverse, CAGACACCTCCTCGCCTTT; Nod2 forward, AACT
GTCCAACAATGGCATCAC; Nod2 reverse, TTCCCTCGAAGCCAAACCT;
b-actin forward, AGAGGGAAATCGTGCGTGGAC; and b-actin reverse, CAA
TAGTGATGACCTGGCCGT. Nod1 or Nod2 to b-actin relative expression
was calculated using the 2(Ct) method.
Mouse Stimulation and Infection
Mice were treated with poly I:C (200 mg/mouse), PEG-mIFN-b (5 3 103
U/mouse) i.p., or rmIFN-b (2.5 3 104 U/mouse) twice s.c. or infected with
MNV-1 (13 107 pfu/mouse orally or 13 106 pfu/mouse i.p.) and 18–24 hr later
injected with PBS or MDP (300 mg/mouse) i.p. or infected with 3 3 108 cfu of
E. coli i.p. or P. aeruginosa 2.5 3 107 i.n. Cytokine levels in serum or lung
homogenates were determined 3 hr postinfection. The survival rate of infected
mice was monitored for 5 days after challenge with E. coli or P. aeruginosa.
Statistical Analysis
Statistically significant differences between two groups were determined by
the two-tailed t test with unequal variance (Aspin-Welch’s t test). Bacterial
counts of infected mice were analyzed by Mann-Whitney U test. The survival
rate of infected mice was analyzed using the log rank test. Differences were
considered significant when p values were < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.chom.2011.05.006.
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